Macquarie Group
IDYA icon

Macquarie Group’s IDEAYA Biosciences IDYA Stock Holding History

Macquarie Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-638,884
Closed -$20.2M – 1690
2024
Q3 		$20.2M Buy
638,884
+380,714
+147% +$14.4M 0.02% 663
2024
Q2 		$9.06M Buy
+258,170
New +$10.2M 0.01% 830

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Macquarie Group's IDYA Position: Q4 2024 in Review

Macquarie Group sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 638,884 shares — an estimated $20.2M sold.

Macquarie Group first reported a position in IDYA in Q2 2024 and held it in 2 quarters. The position peaked at $20.2M in Q3 2024. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

  • Macquarie Group reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
  • Macquarie Group sold 638,884 IDEAYA Biosciences shares in Q4 2024, an estimated $20.2M.
  • Macquarie Group first reported a position in IDEAYA Biosciences in Q2 2024 and held it in 2 quarters.
  • Macquarie Group's IDEAYA Biosciences position peaked at $20.2M in Q3 2024.
  • 206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on Macquarie Group's 13F filing for Q4 2024, filed 14 Feb 2025.